Minimally Invasive Procedure With GraMedica Stent Aligns Feet, Improving Activity Level and Stabilizing Blood Sugar

Macomb, Michigan (PRWEB) November 03, 2015

Every seven seconds someone dies from it, every 20 seconds someone loses a limb to it. What we’re talking about is Diabetes.

As a matter of fact, if the victims of diabetes had their own county it would be the fourth largest in the world.

Just in time for Diabetes Awareness Month-GraMedica, a global orthopedic foot solutions company, wants to help the millions of Americans dealing with diabetes get back on their feet again.

Problem is, many diabetics have misaligned feet where the ankle bone is not properly aligned with the heel bone. This creates an imbalance of forces negatively impacting the alignment within the foot and can also affect the alignment of the knees, hips and back. The more active someone is with misaligned feet, the more pain they experience in their entire body. If you hurt when you exercise, you stop. Hence, why it’s very challenging to get many diabetics inspired to get the exercise they desperately need to control their blood sugar levels.

The revolutionary FDA cleared titanium stent is called HyProCure® . The minimally invasive procedure, which takes only 20 minutes and has a 94% success rate, involves the placement of this small stent into the naturally occurring space in between the ankle and heel bones. Instantly, the foot is realigned and the natural range of motion is restored. Within a week after surgery, patients are able to walk without the excessive strain acting on their feet, knees, hips or back.

Currently, most people with misaligned feet are told to buy new supportive shoes or specialized arch supports to wear in their shoes. For many this is all that is required to help put that spring back in their step. Unfortunately, there is still a large patient population that finds no improvement. Typically, they are told the only other option is reconstructive surgery where the cure can be often be worse than the disease. In our video press release, pre-diabetic patient, Cindi Pallilonis shares how this minimally invasive foot procedure allowed her to shed off over one hundred and twenty five pounds. She has completed six marathons, competed in triathlons and recently just ran the Great Wall of China.

If you are a diabetic who suffers when you try to exercise, it's important to see a foot specialist who can provide a options to get you active again. For more information or to find a foot specialist, log onto http://www.apma.org
About GraMedica
Dr. Michael E. Graham is the Founder and CEO of GraMedica, a global orthopedic foot solutions company, whose premiere product, HyProCure, has been FDA cleared for more than 11 years. HyProCure is a titanium stent that is inserted between the ankle and heel bones to realign the hindfoot and is used by leading foot and ankle surgeons worldwide in nearly 60 countries.

advertisement | advertise on newsday

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/10/prweb13018565.htm